Northcape Wealth Management LLC Grows Stock Holdings in UnitedHealth Group Incorporated $UNH

Northcape Wealth Management LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 89.6% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,347 shares of the healthcare conglomerate’s stock after buying an additional 3,944 shares during the quarter. Northcape Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,604,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Next Capital Management LLC lifted its stake in UnitedHealth Group by 142.4% in the 2nd quarter. Next Capital Management LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $389,000 after purchasing an additional 732 shares in the last quarter. American Capital Advisory LLC lifted its stake in UnitedHealth Group by 147.8% in the 2nd quarter. American Capital Advisory LLC now owns 518 shares of the healthcare conglomerate’s stock worth $162,000 after purchasing an additional 309 shares in the last quarter. Obermeyer Wealth Partners lifted its stake in UnitedHealth Group by 49.3% in the 2nd quarter. Obermeyer Wealth Partners now owns 113,337 shares of the healthcare conglomerate’s stock worth $35,358,000 after purchasing an additional 37,435 shares in the last quarter. Freestone Capital Holdings LLC lifted its stake in UnitedHealth Group by 39.4% in the 2nd quarter. Freestone Capital Holdings LLC now owns 33,040 shares of the healthcare conglomerate’s stock worth $10,308,000 after purchasing an additional 9,332 shares in the last quarter. Finally, Seelaus Asset Management LLC raised its position in shares of UnitedHealth Group by 11.7% during the 2nd quarter. Seelaus Asset Management LLC now owns 1,047 shares of the healthcare conglomerate’s stock valued at $327,000 after buying an additional 110 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $333.87 on Tuesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The firm has a market capitalization of $302.43 billion, a P/E ratio of 17.43, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company’s 50-day moving average is $344.08 and its 200 day moving average is $324.95. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $7.15 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on UNH shares. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research report on Friday, October 17th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Sanford C. Bernstein upped their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Finally, The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price objective on the stock. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.